Omeros (OMER) Other Accumulated Expenses (2011 - 2026)
Omeros (OMER) reported Other Accumulated Expenses of $617000.0 for Q1 2026, up 10.18% on a YoY basis from $560000.0 in Q1 2025, and up 63.23% sequentially from $378000.0 in Q4 2025.
Omeros (OMER) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
Omeros (OMER) has 12 years of Other Accumulated Expenses data on file, last reported at $617000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses rose 10.18% year-over-year to $617000.0; the trailing twelve-month figure through Mar 2026 stood at $617000.0 (up 10.18% YoY), and the FY2025 full-year result was $378000.0, up 92.86% from the prior year.
- Other Accumulated Expenses rose to $617000.0 in Q1 2026, from $378000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $30.6 million in Q4 2022 to a low of $196000.0 in Q4 2024.
- A 5-year average of $7.0 million and a median of $674000.0 in 2022 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses tumbled 98.97% in 2023 and soared 4158.17% in 2024, its largest moves.
- Tracing OMER's Other Accumulated Expenses over 5 years: stood at $30.6 million in 2022, then plunged by 98.97% to $316000.0 in 2023, then sank by 37.97% to $196000.0 in 2024, then surged by 92.86% to $378000.0 in 2025, then jumped by 63.23% to $617000.0 in 2026.
- Business Quant data shows OMER's Other Accumulated Expenses at $617000.0 in Q1 2026, $378000.0 in Q4 2025, and $272000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - |
| 10 | Omeros | 818.49 Mn | 818.49 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 617,000.00 |
| Dec 31, 2025 | 378,000.00 |
| Sep 30, 2025 | 272,000.00 |
| Jun 30, 2025 | 335,000.00 |
| Mar 31, 2025 | 560,000.00 |
| Dec 31, 2024 | 196,000.00 |
| Sep 30, 2024 | 23.25 Mn |
| Jun 30, 2024 | 27.97 Mn |
| Mar 31, 2024 | 28.40 Mn |
| Dec 31, 2023 | 316,000.00 |
| Sep 30, 2023 | 858,000.00 |
| Jun 30, 2023 | 847,000.00 |
| Mar 31, 2023 | 667,000.00 |
| Dec 31, 2022 | 30.55 Mn |
| Sep 30, 2022 | 674,000.00 |
| Jun 30, 2022 | 1.40 Mn |
| Mar 31, 2022 | 1.41 Mn |
| Dec 31, 2021 | 1.68 Mn |
| Sep 30, 2021 | 746,000.00 |
| Jun 30, 2021 | 484,000.00 |